Perspective Therapeutics (CATX) Acquisitions (2023)
Perspective Therapeutics (CATX) posted Acquisitions of $2.7 million for Q1 2023.
Perspective Therapeutics (CATX) Acquisitions (2023) Analysis & Trends
Perspective Therapeutics has reported Acquisitions for 1 years, with the latest figure at $2.7 million in Q1 2023.
- Quarterly Acquisitions changed N/A year-over-year to $2.7 million in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $2.7 million (changed N/A YoY) and the FY2023 annual result came in at $2.7 million, changed N/A from the prior year.
- Acquisitions steadied at $2.7 million in Q1 2023 per CATX's latest filing.
- Over five years, Acquisitions peaked at $2.7 million in Q1 2023 and troughed at $2.7 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 437.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 406.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -4.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -3.49 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 16.00 Mn |
| 10 | Perspective Therapeutics | 389.10 Mn | 389.10 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 2.70 Mn |